PT-141 (Bremelanotide) Nasal Spray is a formulation of the synthetic peptide bremelanotide, often referred to as PT-141. It acts as a melanocortin receptor agonist, primarily targeting receptors in the central nervous system (such as MC1R to MC5R) to enhance sexual arousal and desire.

Unlike traditional erectile dysfunction medications (e.g., Viagra or Cialis) that focus on improving blood flow, PT-141 works neurologically by stimulating brain pathways involved in sexual motivation, libido, and responsiveness. This makes it suitable for addressing low sexual desire or arousal issues in both men and women.

Key Features and Uses

• Primary Purpose: Boosts libido, sexual desire, arousal, and pleasure. It’s used off-label for men with erectile dysfunction (especially those unresponsive to PDE5 inhibitors) and for women with hypoactive sexual desire disorder (HSDD). The FDA-approved form (Vyleesi) is a subcutaneous injection for premenopausal women with HSDD, but nasal spray versions are commonly available through compounding pharmacies for broader use.
• Administration: Delivered as an intranasal spray for convenient, needle-free use. It’s absorbed quickly through the nasal mucosa.
• Onset and Duration: Effects typically begin within 30–60 minutes (sometimes faster), with increased sexual responsiveness lasting 4–12 hours, though intensity may vary.
• Typical Dosage (from compounding sources and user reports): Often 1–2 sprays per nostril (concentrations like 5–10 mg/mL), taken 45–60 minutes before anticipated sexual activity. Dosing starts low (e.g., equivalent to 1–2 mg) and adjusts based on response. Limit to one dose per 24 hours and no more than 8 doses per month to minimize side effects.
• Advantages of Nasal Spray: Faster absorption than some methods, discreet, painless, and avoids injections.

Potential Side Effects

Common ones include nausea (dose-dependent and often the most reported), flushing, headache, nasal irritation (e.g., dryness or minor bleeding in some cases), temporary blood pressure changes, or malaise. These are generally more pronounced with higher doses or nasal routes compared to injections in some studies.

Note that while early research used intranasal forms and many compounding pharmacies offer nasal sprays, the officially FDA-approved version is injectable. Availability and exact formulations can vary, so it’s typically obtained via prescription from specialized providers or compounding pharmacies.

Always consult a healthcare professional for personalized advice, as this is a prescription peptide with potential risks and variable individual responses.